Table 3.
Visit 1 | Visit 2 | P value | |
---|---|---|---|
Blood cell type | |||
CD4+ | 189 (68–523) | 358 (165–479) | 0.0002* |
%CD4+ that are HLADR+ | 15 (12–25) | 8 (5–13) | 0.007* |
CD8+ | 672 (457–1484) | 772 (603–1089) | 0.80 |
%CD8+ that are HLADR+ | 15 (7–25) | 7 (2–9) | 0.001* |
CD4/CD8 | 0.19 (0.13–0.34) | 0.41 (0.22–0.65) | 0.021* |
CD19+ | 163 (94–296) | 300 (182–464) | 0.007* |
NK | 91 (64–154) | 118 (69–154) | 0.99 |
Monocytes total | 325 (227–436) | 312 (195–415) | 0.31 |
Monocytes (%classical) | 75% (68%–85%) | 81% (72%–86%) | 0.25 |
Monocytes (%intermediate) | 11% (6%–15%) | 5% (3%–8%) | 0.01* |
Monocytes (%non-classical) | 12% (6%–18%) | 12% (10%–17%) | 0.55 |
CSF cell type | |||
CD4 | 593 (56–1472) | 391 (116–731) | 0.09 |
%CD4+ that are HLADR+ | 13 (9–24) | 7 (6–10) | 0.003* |
CD8 | 1696 (316–5800) | 797 (329–1579) | 0.006* |
%CD8+ that are HLADR+ | 16 (6–25) | 6 (2–8) | 0.0003* |
CD4/CD8 | 0.34 (0.11–0.55) | 0.44 (0.35–0.64) | 0.02* |
CD19 | 94 (31–270) | 42 (21–57) | 0.002* |
NK | 53 (16–89) | 16 (10–39) | 0.027* |
Monocytes total | 39 (15–55) | 23 (10–62) | 0.39 |
Monocytes (%classical) | 30% (25%–36%) | 37% (25%–43%) | 0.42 |
Monocytes (%intermediate) | 54% (43%–63%) | 57% (49%–67%) | 0.45 |
Monocytes (%non-classical) | 13% (9%–19%) | 8% (6%–14%) | 0.03* |
P values < .05 are denoted by asterisk.